-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Latest From Biotech Now
Banning Gene Patents Will Promote Innovation?
Abolishing gene patents will deter, not promote, innovation, as the patent eligibility of isolated DNA molecules provides incentives necessary for development of life-enhancing diagnostics and therapeutics. R&D to identify genes, their sequences, genetic variations, and their disease correlation is very costly. Claims like those of the patents at issue in the Myriad Genetics lawsuit have been a key foundation supporting the massive investment of time and capital that is necessary to bring life-enhancing DNA-based diagnostics Read More >
2011 BIO International Convention: Posts from BIO’s Official Bloggers
Couldn’t make this year’s 2011 BIO International Convention? Did you miss an interesting session? Do you want to hear an insider’s view of what happened or what you missed? If so, you should check out these posts from members of BIO’s Official Blogger program: BIO Convention 2011, Brady Huggett at Trade Secrets – follow Brady at @naturebiotech Canada Kicks Off BIO, Mike Spear at Genome Alberta – follow Mike at @mikesgene If Biotech Builds… Will Read More >
Docs at BIO: Steve Burrill’s State of the Biotechnology Industry Report 2011
Kevin Noonan from patent Patent Docs writes: The underlying theme of his message this year was that the predominant feature of the biotechnology environment is change, and rapid change. Such change provides challenges but in characteristic fashion Mr. Burrill … espoused the belief that change provides “extraordinary opportunities.” Patent Docs is part of our BIO Official Blogger Program.
Celebrating 30 Years of Biotechnology Innovation: From Diamond v. Chakrabarty to Today
David Kappos, Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO), provided opening remarks at an event entitled, Celebrating 30 years of Biotechnology Innovation: From Diamond v. Chakrabarty to Today during the 2011 BIO International Convention. The forum, co-sponsored by the US Patent and Trademark Office, The Biotechnology Industry Organization and the Biojudiciary Project, celebrated the 30th anniversary of the issuance of the patent from the Supreme Read More >
Five things you need to know about the state of the industry
What is the state of the biotechnology industry? To find out where the it stands and what strategies you need to survive, read Ernst & Young’s 25th annual industry report, Beyond borders: global biotechnology report 2011, that was released during a super session at the 2011 BIO International Convention. What were the industry’s profits last year? What kind of companies received funding? How should you engage the regulators? What new competencies do you need to Read More >
